About Healthcare News
FTC sues important pharmacy benefit administrators around insulin selling prices The agency brought motion from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of life-saving insulin prescription drugs.Elevance lowers direction on ‘unparallel